What We Do
The Medical Writing Partner Your Team Has Been Looking For
The documents your team writes aren’t just paperwork. They’re what carry your science through every regulatory milestone, from investigational new drug application (IND) submissions to marketing applications. How clearly and consistently they tell your product’s story has a real impact on regulatory outcomes and, ultimately, on when patients get access to your therapy.
We partner with small and mid-size biotech and pharmaceutical clinical development teams to provide medical writing services that go beyond drafting text. Whether your program involves small molecules or biologics, we integrate with your team to lead the document development process from planning through finalization, bringing the program knowledge and collaborative approach that lean teams need to move confidently through every stage of the pipeline.
Our writers have supported programs across a range of therapeutic areas, including dermatology, gene therapy, hematology/oncology, hepatology, immunology, neurology, ophthalmology, pulmonology, rare disease, and more.
Marketing Application Submissions
Your marketing application is the culmination of years of work, and the clinical Module 2 components, like the clinical overview (Module 2.5) and clinical summaries (Module 2.7.x), have to hold up. They need to tell a clear, cohesive story across your entire development program — one that reflects the strength of your data and stands up to the scrutiny of regulatory agencies.
We bring expert authoring and medical writing leadership to New Drug Application (NDA), Biologics License Application (BLA), and Marketing Authorisation Application (MAA) components.
Because our writers stay with your program over time, they build the kind of deep familiarity with your regulatory history, data, and strategy that you can’t get from a rotating cast of contractors. The result: strong, cohesive submission documents from the outset.
Clinical Overview (Module 2.5)
The clinical overview is the strategic narrative at the heart of your submission — it synthesizes your entire clinical development program and positions your product for approval. We draw on our deep familiarity with your regulatory history, agency interactions, and development rationale to craft an overview that tells a cohesive, compelling story across studies.
Summary of Clinical Efficacy (Module 2.7.3)
Your efficacy data tell a story, but it doesn’t organize itself. We partner with your biostatistics, clinical, and regulatory teams to determine how best to present results across studies — what to emphasize, how to structure the narrative, and how to align it all with the arguments you’re making in the rest of your submission.
Summary of Clinical Safety (Module 2.7.4)
A well-organized safety summary shows regulators that your team has a thorough understanding of your product’s safety profile. We bring a participant-focused approach to safety writing, ensuring program-wide findings are presented consistently and clearly across your submission package.
Integrated Summary of Safety (ISS) and Integrated Summary of Effectiveness (ISE)
The cross-study analyses in your ISS and ISE form the foundation of your submission’s clinical arguments and benefit-risk profile. We build integrated summaries that are data-driven and robust, internally consistent, strategically organized, and aligned with higher-level messaging in Module 2.
Clinical Study Documentation
Well-crafted clinical study documents set the stage for successful trials, efficient regulatory interactions, and clean study reporting. Whether you’re preparing to open a new study or finalizing results, we provide medical writing services that bring clarity, accuracy, and internal consistency to every deliverable.
Clinical Study Protocols and Amendments
We write protocols that are clear, internally consistent, and aligned with your broader development strategy. If your study design changes, we tackle amendments efficiently, without sacrificing document quality, even under tight timelines. Our processes balance speed with the rigor your team and regulators expect.
Clinical Study Reports (CSRs)
Our CSR writing combines a deep understanding of International Council for Harmonisation (ICH) E3 guidelines with a strategic approach to presenting your study results. We work closely with biostatistics, clinical, and regulatory team members to ensure the report accurately reflects your data and key messages, supports downstream submission documents, and stands up to regulatory scrutiny.
Investigator’s Brochures (IBs)
We develop and maintain IBs that provide investigators and ethics committees with comprehensive, up-to-date information. As your program evolves, we keep IBs aligned with the latest clinical and nonclinical findings.
Regulatory Agency Interactions
How well your regulatory interactions go depends largely on what you put on paper beforehand. We partner with your team to develop the documents that make these critical touchpoints productive.
Briefing Documents and Meeting Packages
From FDA Type A, B, C, and D meetings to EMA Scientific Advice procedures, we author briefing documents that present your development strategy, data, and questions with clarity and purpose.
Responses to Regulatory Information Requests
When regulatory agencies follow up with questions or requests for additional information, timely and thorough responses are essential. We work efficiently with your team to develop well-organized responses that address each point clearly and maintain consistency with your broader regulatory narrative.
Special Designation Applications
Breakthrough Therapy, Fast Track, Orphan Drug, and other special designations can meaningfully accelerate your development path. We author designation applications that make a compelling case for your product by connecting your data to the regulatory criteria.
Safety and Pharmacovigilance Writing
Accurate and timely safety documentation protects patients, meets regulatory obligations, and supports the integrity of your clinical program. We bring a thoughtful, participant‑focused approach to every safety deliverable.
Development Safety Update Reports (DSURs)
We author DSURs that provide regulators with a clear, current picture of your product’s safety profile, meeting annual reporting requirements with precision and consistency.
Patient Narratives
Our narrative writing tells the clinical story of individual patient experiences with accuracy and appropriate detail, contextualizing important safety events and supporting submission requirements.
Ongoing Safety Documentation
From safety review committee presentations to interim safety analyses, we support the documentation your team needs to maintain vigilant safety oversight throughout your clinical program.
Document Development Leadership
What happens when the document development process itself becomes the bottleneck?
Medical writing is more than putting words on a page. The planning, coordination, review management, and quality control that surround authoring are where timelines are won or lost and where consistency is built or eroded.
We provide end-to-end collaborative authoring leadership that removes the administrative and coordination burden from your team so they can focus on clinical and regulatory strategy.
We’ve found that the most effective document development happens when medical writers are involved early, not just when it’s time to draft. Early engagement gives us the program knowledge and team relationships that accelerate every deliverable that follows. Less stress. Better documents. On‑time submissions.
Program-level document planning
We review your regulatory history and upcoming milestones to map out deliverables, timelines, and dependencies across your pipeline.
Document shell development and first drafts
We build document frameworks that give cross-functional contributors clear structure and context, so their input is focused and efficient from the start.
Timeline generation and milestone tracking
We create realistic timelines that account for review cycles, adjudication meetings, quality checks, and a focused approach to collaborative authoring for busy teams.
Kickoff and adjudication meeting facilitation
We lead meetings that align stakeholders, resolve comments efficiently, and keep documents moving forward.
Review management and quality control
We manage comment resolution across drafts, guide reviewers toward the content that matters most, and apply rigorous quality checks before every deliverable leaves our hands.
Why Teams Partner with Us
Our clients are looking for something different.
If you’ve worked with large agencies or rotating freelancers, you know the frustration of starting over every time. Our model is built to eliminate that.
Program mastery through long-term partnerships
We’re dedicated to your program and strive to develop deep knowledge of your product, regulatory history, and team dynamics. Our model is built to eliminate the constraints of individual contributors and turnover of large service providers — and it shows in cleaner drafts, faster review cycles, and documents that get stronger with every deliverable.
Experts who move your documents forward
Our writers have broad experience across major clinical and regulatory document types. You won’t spend your time training, hand-holding, or extensively revising our work. We deliver clean, strategic drafts that are ready for your team’s focused review.
An interconnected team with built-in resilience
We operate as a connected team with common standards for quality and client engagement. That structure means built-in backup support, so your timelines are protected, your document quality stays consistent, and your team can scale without starting over.
An agility mindset when your plans change
Clinical development rarely follows a straight line. We bring a can-do attitude of unruffled project leadership to every engagement, adapting timelines, pivoting scope, and finding ways to keep your documents moving forward when the unexpected happens.
A shared commitment to patients
We never lose sight of why this work matters. Every document we write contributes to the larger goal of bringing life-changing therapies to patients who need them. That sense of purpose drives the quality and care we bring to every engagement.